カテゴリー： Market Monitor Global, 世界, 医療/バイオ

アルツハイマー病治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Alzheimer Treatment Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5642）◆商品コード：MMG23JU5642
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Alzheimer Treatment Drug Market 調査レポートは次の情報を含め、グローバルにおけるのアルツハイマー病治療薬市場規模と予測を収録しています。・世界のアルツハイマー病治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のアルツハイマー病治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアルツハイマー病治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ドネペジル」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

アルツハイマー病治療薬のグローバル主要企業は、Allergan、 Eisai、 Novartis、 Daiichi Sankyo、 Merz Pharma、 Pfizer、 Johnson & Johnson、 Lundbeckなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、アルツハイマー病治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のアルツハイマー病治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のアルツハイマー病治療薬市場：タイプ別市場シェア、2022年
・ドネペジル、メマンチン、リバスチグミン、その他

世界のアルツハイマー病治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のアルツハイマー病治療薬市場：用途別市場シェア、2022年
・初期-中期、中等度-重症

世界のアルツハイマー病治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のアルツハイマー病治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるアルツハイマー病治療薬のグローバル売上、2018年-2023年
・主要企業におけるアルツハイマー病治療薬のグローバル売上シェア、2022年
・主要企業におけるアルツハイマー病治療薬のグローバル販売量、2018年-2023年
・主要企業におけるアルツハイマー病治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Allergan、 Eisai、 Novartis、 Daiichi Sankyo、 Merz Pharma、 Pfizer、 Johnson & Johnson、 Lundbeck

*************************************************************

・調査・分析レポートの概要
アルツハイマー病治療薬市場の定義
市場セグメント
世界のアルツハイマー病治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアルツハイマー病治療薬市場規模
世界のアルツハイマー病治療薬市場規模：2022年 VS 2029年
世界のアルツハイマー病治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアルツハイマー病治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアルツハイマー病治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ドネペジル、メマンチン、リバスチグミン、その他
アルツハイマー病治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：初期-中期、中等度-重症
アルツハイマー病治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別アルツハイマー病治療薬市場規模 2022年と2029年
地域別アルツハイマー病治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Allergan、 Eisai、 Novartis、 Daiichi Sankyo、 Merz Pharma、 Pfizer、 Johnson & Johnson、 Lundbeck
...

Alzheimer’s disease (AD), also referred to simply as Alzheimer’s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
This report aims to provide a comprehensive presentation of the global market for Alzheimer Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer Treatment Drug. This report contains market size and forecasts of Alzheimer Treatment Drug in global, including the following market information:
Global Alzheimer Treatment Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Alzheimer Treatment Drug Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Alzheimer Treatment Drug companies in 2022 (%)
The global Alzheimer Treatment Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Donepezil Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Alzheimer Treatment Drug include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson and Lundbeck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer Treatment Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer Treatment Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Alzheimer Treatment Drug Market Segment Percentages, by Type, 2022 (%)
Donepezil
Memantine
Rivastigmine
Other
Global Alzheimer Treatment Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Alzheimer Treatment Drug Market Segment Percentages, by Application, 2022 (%)
Early to Moderate Stages
Moderate to Severe Stages
Global Alzheimer Treatment Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Alzheimer Treatment Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer Treatment Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Alzheimer Treatment Drug revenues share in global market, 2022 (%)
Key companies Alzheimer Treatment Drug sales in global market, 2018-2023 (Estimated), (Units)
Key companies Alzheimer Treatment Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alzheimer Treatment Drug, market overview.
Chapter 2: Global Alzheimer Treatment Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Alzheimer Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alzheimer Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Alzheimer Treatment Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Alzheimer Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alzheimer Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alzheimer Treatment Drug Overall Market Size
2.1 Global Alzheimer Treatment Drug Market Size: 2022 VS 2029
2.2 Global Alzheimer Treatment Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Alzheimer Treatment Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Alzheimer Treatment Drug Players in Global Market
3.2 Top Global Alzheimer Treatment Drug Companies Ranked by Revenue
3.3 Global Alzheimer Treatment Drug Revenue by Companies
3.4 Global Alzheimer Treatment Drug Sales by Companies
3.5 Global Alzheimer Treatment Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Alzheimer Treatment Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Alzheimer Treatment Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Alzheimer Treatment Drug Players in Global Market
3.8.1 List of Global Tier 1 Alzheimer Treatment Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Alzheimer Treatment Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Alzheimer Treatment Drug Market Size Markets, 2022 & 2029
4.1.2 Donepezil
4.1.3 Memantine
4.1.4 Rivastigmine
4.1.5 Other
4.2 By Type – Global Alzheimer Treatment Drug Revenue & Forecasts
4.2.1 By Type – Global Alzheimer Treatment Drug Revenue, 2018-2023
4.2.2 By Type – Global Alzheimer Treatment Drug Revenue, 2024-2029
4.2.3 By Type – Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Alzheimer Treatment Drug Sales & Forecasts
4.3.1 By Type – Global Alzheimer Treatment Drug Sales, 2018-2023
4.3.2 By Type – Global Alzheimer Treatment Drug Sales, 2024-2029
4.3.3 By Type – Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
4.4 By Type – Global Alzheimer Treatment Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Alzheimer Treatment Drug Market Size, 2022 & 2029
5.1.2 Early to Moderate Stages
5.1.3 Moderate to Severe Stages
5.2 By Application – Global Alzheimer Treatment Drug Revenue & Forecasts
5.2.1 By Application – Global Alzheimer Treatment Drug Revenue, 2018-2023
5.2.2 By Application – Global Alzheimer Treatment Drug Revenue, 2024-2029
5.2.3 By Application – Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Alzheimer Treatment Drug Sales & Forecasts
5.3.1 By Application – Global Alzheimer Treatment Drug Sales, 2018-2023
5.3.2 By Application – Global Alzheimer Treatment Drug Sales, 2024-2029
5.3.3 By Application – Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
5.4 By Application – Global Alzheimer Treatment Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Alzheimer Treatment Drug Market Size, 2022 & 2029
6.2 By Region – Global Alzheimer Treatment Drug Revenue & Forecasts
6.2.1 By Region – Global Alzheimer Treatment Drug Revenue, 2018-2023
6.2.2 By Region – Global Alzheimer Treatment Drug Revenue, 2024-2029
6.2.3 By Region – Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Alzheimer Treatment Drug Sales & Forecasts
6.3.1 By Region – Global Alzheimer Treatment Drug Sales, 2018-2023
6.3.2 By Region – Global Alzheimer Treatment Drug Sales, 2024-2029
6.3.3 By Region – Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Alzheimer Treatment Drug Revenue, 2018-2029
6.4.2 By Country – North America Alzheimer Treatment Drug Sales, 2018-2029
6.4.3 US Alzheimer Treatment Drug Market Size, 2018-2029
6.4.4 Canada Alzheimer Treatment Drug Market Size, 2018-2029
6.4.5 Mexico Alzheimer Treatment Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Alzheimer Treatment Drug Revenue, 2018-2029
6.5.2 By Country – Europe Alzheimer Treatment Drug Sales, 2018-2029
6.5.3 Germany Alzheimer Treatment Drug Market Size, 2018-2029
6.5.4 France Alzheimer Treatment Drug Market Size, 2018-2029
6.5.5 U.K. Alzheimer Treatment Drug Market Size, 2018-2029
6.5.6 Italy Alzheimer Treatment Drug Market Size, 2018-2029
6.5.7 Russia Alzheimer Treatment Drug Market Size, 2018-2029
6.5.8 Nordic Countries Alzheimer Treatment Drug Market Size, 2018-2029
6.5.9 Benelux Alzheimer Treatment Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Alzheimer Treatment Drug Revenue, 2018-2029
6.6.2 By Region – Asia Alzheimer Treatment Drug Sales, 2018-2029
6.6.3 China Alzheimer Treatment Drug Market Size, 2018-2029
6.6.4 Japan Alzheimer Treatment Drug Market Size, 2018-2029
6.6.5 South Korea Alzheimer Treatment Drug Market Size, 2018-2029
6.6.6 Southeast Asia Alzheimer Treatment Drug Market Size, 2018-2029
6.6.7 India Alzheimer Treatment Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Alzheimer Treatment Drug Revenue, 2018-2029
6.7.2 By Country – South America Alzheimer Treatment Drug Sales, 2018-2029
6.7.3 Brazil Alzheimer Treatment Drug Market Size, 2018-2029
6.7.4 Argentina Alzheimer Treatment Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Alzheimer Treatment Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Alzheimer Treatment Drug Sales, 2018-2029
6.8.3 Turkey Alzheimer Treatment Drug Market Size, 2018-2029
6.8.4 Israel Alzheimer Treatment Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Alzheimer Treatment Drug Market Size, 2018-2029
6.8.6 UAE Alzheimer Treatment Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Alzheimer Treatment Drug Major Product Offerings
7.1.4 Allergan Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Alzheimer Treatment Drug Major Product Offerings
7.2.4 Eisai Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Alzheimer Treatment Drug Major Product Offerings
7.3.4 Novartis Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Daiichi Sankyo
7.4.1 Daiichi Sankyo Company Summary
7.4.2 Daiichi Sankyo Business Overview
7.4.3 Daiichi Sankyo Alzheimer Treatment Drug Major Product Offerings
7.4.4 Daiichi Sankyo Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.4.5 Daiichi Sankyo Key News & Latest Developments
7.5 Merz Pharma
7.5.1 Merz Pharma Company Summary
7.5.2 Merz Pharma Business Overview
7.5.3 Merz Pharma Alzheimer Treatment Drug Major Product Offerings
7.5.4 Merz Pharma Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.5.5 Merz Pharma Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Alzheimer Treatment Drug Major Product Offerings
7.6.4 Pfizer Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Alzheimer Treatment Drug Major Product Offerings
7.7.4 Johnson & Johnson Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Lundbeck
7.8.1 Lundbeck Company Summary
7.8.2 Lundbeck Business Overview
7.8.3 Lundbeck Alzheimer Treatment Drug Major Product Offerings
7.8.4 Lundbeck Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.8.5 Lundbeck Key News & Latest Developments
8 Global Alzheimer Treatment Drug Production Capacity, Analysis
8.1 Global Alzheimer Treatment Drug Production Capacity, 2018-2029
8.2 Alzheimer Treatment Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Alzheimer Treatment Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Alzheimer Treatment Drug Supply Chain Analysis
10.1 Alzheimer Treatment Drug Industry Value Chain
10.2 Alzheimer Treatment Drug Upstream Market
10.3 Alzheimer Treatment Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Alzheimer Treatment Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Alzheimer Treatment Drug in Global Market
Table 2. Top Alzheimer Treatment Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Alzheimer Treatment Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Alzheimer Treatment Drug Revenue Share by Companies, 2018-2023
Table 5. Global Alzheimer Treatment Drug Sales by Companies, (Units), 2018-2023
Table 6. Global Alzheimer Treatment Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Alzheimer Treatment Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Alzheimer Treatment Drug Product Type
Table 9. List of Global Tier 1 Alzheimer Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Alzheimer Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Alzheimer Treatment Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Alzheimer Treatment Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Alzheimer Treatment Drug Sales (Units), 2018-2023
Table 15. By Type - Global Alzheimer Treatment Drug Sales (Units), 2024-2029
Table 16. By Application – Global Alzheimer Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Alzheimer Treatment Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Alzheimer Treatment Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Alzheimer Treatment Drug Sales (Units), 2018-2023
Table 20. By Application - Global Alzheimer Treatment Drug Sales (Units), 2024-2029
Table 21. By Region – Global Alzheimer Treatment Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Alzheimer Treatment Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Alzheimer Treatment Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Alzheimer Treatment Drug Sales (Units), 2018-2023
Table 25. By Region - Global Alzheimer Treatment Drug Sales (Units), 2024-2029
Table 26. By Country - North America Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Alzheimer Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Alzheimer Treatment Drug Sales, (Units), 2018-2023
Table 29. By Country - North America Alzheimer Treatment Drug Sales, (Units), 2024-2029
Table 30. By Country - Europe Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Alzheimer Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Alzheimer Treatment Drug Sales, (Units), 2018-2023
Table 33. By Country - Europe Alzheimer Treatment Drug Sales, (Units), 2024-2029
Table 34. By Region - Asia Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Alzheimer Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Alzheimer Treatment Drug Sales, (Units), 2018-2023
Table 37. By Region - Asia Alzheimer Treatment Drug Sales, (Units), 2024-2029
Table 38. By Country - South America Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Alzheimer Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Alzheimer Treatment Drug Sales, (Units), 2018-2023
Table 41. By Country - South America Alzheimer Treatment Drug Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Alzheimer Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Alzheimer Treatment Drug Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Alzheimer Treatment Drug Sales, (Units), 2024-2029
Table 46. Allergan Company Summary
Table 47. Allergan Alzheimer Treatment Drug Product Offerings
Table 48. Allergan Alzheimer Treatment Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. Eisai Company Summary
Table 51. Eisai Alzheimer Treatment Drug Product Offerings
Table 52. Eisai Alzheimer Treatment Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Eisai Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Alzheimer Treatment Drug Product Offerings
Table 56. Novartis Alzheimer Treatment Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Daiichi Sankyo Company Summary
Table 59. Daiichi Sankyo Alzheimer Treatment Drug Product Offerings
Table 60. Daiichi Sankyo Alzheimer Treatment Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Daiichi Sankyo Key News & Latest Developments
Table 62. Merz Pharma Company Summary
Table 63. Merz Pharma Alzheimer Treatment Drug Product Offerings
Table 64. Merz Pharma Alzheimer Treatment Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Merz Pharma Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Alzheimer Treatment Drug Product Offerings
Table 68. Pfizer Alzheimer Treatment Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Alzheimer Treatment Drug Product Offerings
Table 72. Johnson & Johnson Alzheimer Treatment Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Lundbeck Company Summary
Table 75. Lundbeck Alzheimer Treatment Drug Product Offerings
Table 76. Lundbeck Alzheimer Treatment Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Lundbeck Key News & Latest Developments
Table 78. Alzheimer Treatment Drug Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 79. Global Alzheimer Treatment Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Alzheimer Treatment Drug Production by Region, 2018-2023 (Units)
Table 81. Global Alzheimer Treatment Drug Production by Region, 2024-2029 (Units)
Table 82. Alzheimer Treatment Drug Market Opportunities & Trends in Global Market
Table 83. Alzheimer Treatment Drug Market Drivers in Global Market
Table 84. Alzheimer Treatment Drug Market Restraints in Global Market
Table 85. Alzheimer Treatment Drug Raw Materials
Table 86. Alzheimer Treatment Drug Raw Materials Suppliers in Global Market
Table 87. Typical Alzheimer Treatment Drug Downstream
Table 88. Alzheimer Treatment Drug Downstream Clients in Global Market
Table 89. Alzheimer Treatment Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Alzheimer Treatment Drug Segment by Type in 2022
Figure 2. Alzheimer Treatment Drug Segment by Application in 2022
Figure 3. Global Alzheimer Treatment Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Alzheimer Treatment Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Alzheimer Treatment Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Alzheimer Treatment Drug Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Alzheimer Treatment Drug Revenue in 2022
Figure 9. By Type - Global Alzheimer Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Alzheimer Treatment Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Alzheimer Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Alzheimer Treatment Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Alzheimer Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Alzheimer Treatment Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Alzheimer Treatment Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Alzheimer Treatment Drug Sales Market Share, 2018-2029
Figure 23. US Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Alzheimer Treatment Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Alzheimer Treatment Drug Sales Market Share, 2018-2029
Figure 28. Germany Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Alzheimer Treatment Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Alzheimer Treatment Drug Sales Market Share, 2018-2029
Figure 37. China Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Alzheimer Treatment Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Alzheimer Treatment Drug Sales Market Share, 2018-2029
Figure 44. Brazil Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Alzheimer Treatment Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Alzheimer Treatment Drug Sales Market Share, 2018-2029
Figure 48. Turkey Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Alzheimer Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Alzheimer Treatment Drug Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Alzheimer Treatment Drug by Region, 2022 VS 2029
Figure 54. Alzheimer Treatment Drug Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ アルツハイマー病治療薬の世界市場見通し2023年-2029年(Alzheimer Treatment Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 神経疾患治療薬の世界市場見通し2023年-2029年
  • 軟骨無形成術治療薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆